Aberrant signaling pathways in t-cell acute lymphoblastic leukemia

Deborah Bongiovanni, Valentina Saccomani, Erich Piovan

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the malignant transformation of immature progenitors primed towards T-cell development. Clinically, T-ALL patients present with diffuse infiltration of the bone marrow by immature T-cell blasts high blood cell counts, mediastinal involvement, and diffusion to the central nervous system. In the past decade, the genomic landscape of T-ALL has been the target of intense research. The identification of specific genomic alterations has contributed to identify strong oncogenic drivers and signaling pathways regulating leukemia growth. Notwithstanding, T-ALL patients are still treated with high-dose multiagent chemotherapy, potentially exposing these patients to considerable acute and long-term side effects. This review summarizes recent advances in our understanding of the signaling pathways relevant for the pathogenesis of T-ALL and the opportunities offered for targeted therapy.

Original languageEnglish
Article number1904
JournalInternational Journal of Molecular Sciences
Volume18
Issue number9
DOIs
Publication statusPublished - Sep 5 2017

Fingerprint

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
leukemias
T-cells
Precursor Cell Lymphoblastic Leukemia-Lymphoma
cells
T-Lymphocytes
blood cell count
Blood Cell Count
pathogenesis
central nervous system
bone marrow
blasts
infiltration
chemotherapy
Chemotherapy
Leukemia
Central Nervous System
Neurology
Bone Marrow
therapy

Keywords

  • Acute lymphoblastic leukemia
  • Oncogenes
  • PI3K/AKT
  • Targeted therapy

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Aberrant signaling pathways in t-cell acute lymphoblastic leukemia. / Bongiovanni, Deborah; Saccomani, Valentina; Piovan, Erich.

In: International Journal of Molecular Sciences, Vol. 18, No. 9, 1904, 05.09.2017.

Research output: Contribution to journalReview article

@article{91d11826d46d498bac3c8584c9ffb115,
title = "Aberrant signaling pathways in t-cell acute lymphoblastic leukemia",
abstract = "T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the malignant transformation of immature progenitors primed towards T-cell development. Clinically, T-ALL patients present with diffuse infiltration of the bone marrow by immature T-cell blasts high blood cell counts, mediastinal involvement, and diffusion to the central nervous system. In the past decade, the genomic landscape of T-ALL has been the target of intense research. The identification of specific genomic alterations has contributed to identify strong oncogenic drivers and signaling pathways regulating leukemia growth. Notwithstanding, T-ALL patients are still treated with high-dose multiagent chemotherapy, potentially exposing these patients to considerable acute and long-term side effects. This review summarizes recent advances in our understanding of the signaling pathways relevant for the pathogenesis of T-ALL and the opportunities offered for targeted therapy.",
keywords = "Acute lymphoblastic leukemia, Oncogenes, PI3K/AKT, Targeted therapy",
author = "Deborah Bongiovanni and Valentina Saccomani and Erich Piovan",
year = "2017",
month = "9",
day = "5",
doi = "10.3390/ijms18091904",
language = "English",
volume = "18",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "9",

}

TY - JOUR

T1 - Aberrant signaling pathways in t-cell acute lymphoblastic leukemia

AU - Bongiovanni, Deborah

AU - Saccomani, Valentina

AU - Piovan, Erich

PY - 2017/9/5

Y1 - 2017/9/5

N2 - T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the malignant transformation of immature progenitors primed towards T-cell development. Clinically, T-ALL patients present with diffuse infiltration of the bone marrow by immature T-cell blasts high blood cell counts, mediastinal involvement, and diffusion to the central nervous system. In the past decade, the genomic landscape of T-ALL has been the target of intense research. The identification of specific genomic alterations has contributed to identify strong oncogenic drivers and signaling pathways regulating leukemia growth. Notwithstanding, T-ALL patients are still treated with high-dose multiagent chemotherapy, potentially exposing these patients to considerable acute and long-term side effects. This review summarizes recent advances in our understanding of the signaling pathways relevant for the pathogenesis of T-ALL and the opportunities offered for targeted therapy.

AB - T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the malignant transformation of immature progenitors primed towards T-cell development. Clinically, T-ALL patients present with diffuse infiltration of the bone marrow by immature T-cell blasts high blood cell counts, mediastinal involvement, and diffusion to the central nervous system. In the past decade, the genomic landscape of T-ALL has been the target of intense research. The identification of specific genomic alterations has contributed to identify strong oncogenic drivers and signaling pathways regulating leukemia growth. Notwithstanding, T-ALL patients are still treated with high-dose multiagent chemotherapy, potentially exposing these patients to considerable acute and long-term side effects. This review summarizes recent advances in our understanding of the signaling pathways relevant for the pathogenesis of T-ALL and the opportunities offered for targeted therapy.

KW - Acute lymphoblastic leukemia

KW - Oncogenes

KW - PI3K/AKT

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85029160656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029160656&partnerID=8YFLogxK

U2 - 10.3390/ijms18091904

DO - 10.3390/ijms18091904

M3 - Review article

AN - SCOPUS:85029160656

VL - 18

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 9

M1 - 1904

ER -